← Volver al ranking

Thumbnails similares a Kidney involvement in Sjögren’s Disease (SjD)

20 vecinos (thumb_512) · 401 views · ERN ReCONNET · —

★Kidney involvement in Sjögren’s Disease (SjD)

ERN ReCONNET

@ernreconnet

401—
3Hydroxychloroquine in connective tissue diseases: benefits and controversial aspects

ERN ReCONNET

@ernreconnet

1.8K—74
5IgG4-related disease (IgG4-RD): update on diagnosis and treatments in 2025

ERN ReCONNET

@ernreconnet

1.3K—71
14From basics to updates for cutaneous lupus erythematosus (CLE)

ERN ReCONNET

@ernreconnet

1.1K—68
15Lanzamiento de la Especialización en Gerencia de Instituciones de la salud

EAFIT+

@eafitenvivo

720Colombia68
10Recent advances in the treatment of inflammatory myopathies

ERN ReCONNET

@ernreconnet

618—69
16How to find hidden Antiphospholipid Syndrome (APS)

ERN ReCONNET

@ernreconnet

471—67
4CAR-T Therapy in Systemic Lupus Erythematosus (SLE): Explained to the Patient

ERN ReCONNET

@ernreconnet

441—71
1What is the added value of triple therapy in lupus nephritis?

ERN ReCONNET

@ernreconnet

438—77
17Quality of life in Relapsing Polychondritis (RP)

ERN ReCONNET

@ernreconnet

412—67
8Update on B cell targeting therapies in IgG4-related disease

ERN ReCONNET

@ernreconnet

375—69
11Treatment of systemic sclerosis-associated interstitial lung disease: where do we stand in 2025?

ERN ReCONNET

@ernreconnet

285—69
2Systemic sclerosis and pregnancy, a 2026 update

ERN ReCONNET

@ernreconnet

257—76
12Thrombocytopenia in systemic lupus erythematosus (SLE)

ERN ReCONNET

@ernreconnet

249—68
6Exercise as a non-pharmacological treatment adjunct to pharmacotherapy in systemic sclerosis.

ERN ReCONNET

@ernreconnet

222—70
18The transition from benign to secondary Raynaud’s phenomenon

ERN ReCONNET

@ernreconnet

186—67
9Unconventional therapies in connective tissue diseases

ERN ReCONNET

@ernreconnet

110—69
13Unmet Needs in Childhood-Onset Sjögren's Disease – Patient and Clinician Perspectives

ERN ReCONNET

@ernreconnet

82—68
20Radiología en Urgencias no Traumáticas I y II

Aula MEJOR

@aulamejor

58—66
7Screening and treatment of systemic sclerosis-associated PAH: where do we stand in 2024?

ERN ReCONNET

@ernreconnet

53—69
19Neuromonitorización y Fuentes de Energía, Cirugía de Cáncer Tiroides, Acad. Dr. M. Francisco Herrera

Academia Mexicana de Cirugía A.C.

@academiamexdecirugia

23—67